GSK Investigational Site

Kocaeli, İzmit 41380

2 studies enrolling now · 3 studies all time

What they study most

Liver Diseases, Alcoholic, Multiple Myeloma, Newly Diagnosed Multiple Myeloma, Non-alcoholic Fatty Liver Disease, Nonalcoholic Fatty Liver Disease

Studies at this site

• A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver Disease — Recruiting now
• A Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone (BRd) Versus Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Who Are Ineligible for Autologous Stem Cell Transplantation (TI-NDMM) — Recruiting now
• Phase 2b Study of GSK4532990 in Adults With NASH — Running, not enrolling